Puma Biotechnology Lowers FY2025 Sales Guidance from $212.00M-$222.00M to $192.00M-$198.00M vs $217.80M Est

Benzinga · 4d ago
Puma Biotechnology (NASDAQ:PBYI) lowers FY2025 sales outlook from $212.00 million-$222.00 million to $192.00 million-$198.00 million vs $217.80 million estimate.